Plasma Fractionation Market to Experience Significant Growth by 2027
According to a research report “Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027″ published by MarketsandMarkets, the global plasma fractionation market size...
Plasma Fractionation Market Size, Share, Key Players Analysis Report and Forecast to 2027
Plasma Fractionation Market is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as increased application of immunoglobulins for treatment of various therapeutic areas such as hematology, neurology and pulmonology, and the use of protease inhibitors for the treatment of lung diseases...
What Are Several of the Benefits of Plasma Fractionation Market?
Plasma Fractionation Market in terms of revenue was estimated to be worth $26.5 billion in 2022 and is poised to reach $36.3 billion by 2027, growing at a CAGR of 6.5% from 2022 to 2027. The market size is updated for the base year of 2021 and forecasted from 2022 to 2027 by studying the impact of the overall plasma fractionation industry. The new version of the report includes ranges and scenarios,...
Plasma Fractionation Market Size 2022 Global Industry Analysis by Trends, Future Demands, Top Key Players and Forecast Till 2027
Plasma Fractionation Market in terms of revenue was estimated to be worth $26.5 billion in 2022 and is poised to reach $36.3 billion by 2027, growing at a CAGR of 6.5% from 2022 to 2027. The market size is updated for the base year of 2021 and forecasted from 2022 to 2027 by studying the impact of the overall plasma fractionation industry. The new version of the report includes ranges and scenarios,...
Plasma Fractionation Market worth $36.7 billion by 2027 – Exclusive Report by MarketsandMarkets™
Plasma Fractionation Marketby Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027″ published by MarketsandMarkets, the global plasma fractionation market size is projected to reach USD 36.7 billion by 2027...
Plasma Fractionation Market worth $39.5 billion by 2025 – Exclusive Report by MarketsandMarkets™
According to the new market research report “Plasma Fractionation Market By Product [IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor], Application (Immunology, Hematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics) & Region- Global Forecast to 2025″, published by MarketsandMarkets™,the global Plasma Fractionation...
Plasma Fractionation Market: Geographic growth opportunities and leading key players
Market Overview:
The global plasma fractionation market size is projected to reach USD 39.5 billion by 2025 from USD 28.6 billion in 2020, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), rising geriatric...
Plasma Fractionation Market : Geographical Snapshot
The global plasma fractionation market is projected to reach USD 29.50 Billion by 2023 from USD 21.23 Billion in 2018, at a CAGR of 6.8%. Market growth can be attributed to factors such as the growing use of immunoglobulins in various therapeutic areas, rising geriatric population across the globe, growing prevalence of respiratory diseases and AATD driving the uptake of alpha-1-antitrypsin, and increase...
CSL (Australia) and Grifols (Spain) are the Key Players in the Plasma Fractionation Market
The global plasma fractionation market is projected to reach USD 29.50 Billion by 2023 from USD 21.23 Billion in 2018, at a CAGR of 6.8% during the forecast period. The global plasma fractionation market is consolidated in nature, with top the four players accounting for 60–65% share of the market. In 2017, CSL (Australia), Grifols (Spain), Shire (Ireland), and Octapharma (Switzerland) dominated...
Plasma Fractionation Market : geographic growth analysis and Current industry Trends
The plasma fractionation market is valued at 19.93 Billion in 2017 and is expected to grow at a CAGR of 6.8% during the forecast period (2018 to 2023), to reach to USD 29.50 Billion by 2023. Base year considered for the report is 2017.
Rising new indications for plasma products, rising adoption of SCIg, increasing installation of fractionators in plasma collection centers, and the high growth of the...